Liver Fibrosis Reduced with HIV-Hep C Co-Infection | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

All Cured of Hep C Genotype 2 or 3 in Arm of PSI-7977 Trial

Back to News Homepage
Next

European Union Approves Victrelis for Chronic Hep C

Liver Fibrosis Reduced with HIV-Hep C Co-Infection

The Editors at Hepatitis Central
July 22, 2011

Print this page

In an Italian study of people co-infected with HIV and Hepatitis C, taking Maraviroc helped reduce liver stiffness.

Maraviroc improves liver fibrosis in HIV/hepatitis C co-infected patients

by Michael Carter

July 20, 2011

Treatment with maraviroc is associated with the regression of liver fibrosis in HIV-positive patients co-infected with hepatitis C, a small randomised study presented to the Sixth International AIDS Society conference in Rome shows.

Investigators from the University of Brescia in Italy believe that the beneficial impact of maraviroc (Celsentri) was due to its inhibition of CCR5.

Continue reading this entire article:
http://www.aidsmap.com/page/1882378/

No Comments - be the first!
Share
Share
Previous

All Cured of Hep C Genotype 2 or 3 in Arm of PSI-7977 Trial

Back to News Homepage
Next

European Union Approves Victrelis for Chronic Hep C

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.